rs139896431
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 1P and 14B. PP2BP4_ModerateBP6_Very_StrongBS2
The NM_004380.3(CREBBP):c.3029C>T(p.Pro1010Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000227 in 1,614,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_004380.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CREBBP | NM_004380.3 | c.3029C>T | p.Pro1010Leu | missense_variant | Exon 15 of 31 | ENST00000262367.10 | NP_004371.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CREBBP | ENST00000262367.10 | c.3029C>T | p.Pro1010Leu | missense_variant | Exon 15 of 31 | 1 | NM_004380.3 | ENSP00000262367.5 | ||
CREBBP | ENST00000382070.7 | c.2915C>T | p.Pro972Leu | missense_variant | Exon 14 of 30 | 1 | ENSP00000371502.3 | |||
CREBBP | ENST00000570939.2 | c.1634C>T | p.Pro545Leu | missense_variant | Exon 10 of 23 | 5 | ENSP00000461002.2 | |||
CREBBP | ENST00000573672.1 | n.283C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152140Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000175 AC: 44AN: 251444Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135900
GnomAD4 exome AF: 0.000242 AC: 354AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.000212 AC XY: 154AN XY: 727242
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152140Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74316
ClinVar
Submissions by phenotype
CREBBP-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Rubinstein-Taybi syndrome Benign:1
- -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at